Amplitude Ventures

Amplitude Ventures is a Canadian life sciences venture capital firm focused on building precision medicine companies, with offices in Montreal and Vancouver and a mandate spanning therapeutics, medical devices, and life sciences tools. The firm positions itself as a specialist in Canadian health innovation, partnering with academic institutions, hospital networks, and operator-founders to advance pre-clinical and early clinical assets. Its sector emphasis is on therapeutic platforms, novel modalities, and devices that benefit from rigorous scientific diligence and active company building.

Amplitude invests primarily at Series A and Series B stages, with selective participation in seed rounds where company building is central to the strategy. Geographic activity is concentrated in Canada, with cross-border participation in US-based companies that align with Canadian research collaborations or commercial partnerships. Deal types include traditional equity investments and active company building, where the firm contributes both capital and operating support to construct teams, advance clinical strategy, and prepare companies for follow-on syndication. The firm typically takes a lead or co-lead role with corresponding board engagement.

For founders, Amplitude Ventures combines specialized life sciences capital with hands-on company building tailored to the Canadian innovation ecosystem. The firm is most relevant to therapeutic, device, and life sciences tools teams that benefit from active investor engagement on clinical strategy, syndicate construction, and commercial planning. Founders should expect substantial board involvement, structured milestone planning, and ongoing engagement on team building and follow-on financings. The firm is best suited to scientifically grounded companies pursuing capital-intensive therapeutic or device programs that require a credible Canadian institutional anchor and a multi-round commitment from a specialist life sciences investor.